Shanghai MicroPort Endovascular MedTech Co., Ltd. provided earnings guidance for the year ended December 31, 2020. For the year, the company expected to record an increase in its profit for the year ended 31 December 2020. The net profit attributable to the equity owners of the company is expected to be between RMB 198.46 million and RMB 226.81 million, representing an increase of between 40% and 60% from that of last year. The increase in profit is primarily attributable to the new products launched in recent years of the company that have been steadily admitted for bidding and entered hospitals, which gradually contributed to the revenue increase of the company, and the revenue maintained a satisfactory growth trend during the reporting period.